Barbui C - Search Results

1

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.

Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM. Leucht S, et al. Among authors: barbui c. Lancet. 2013 Sep 14;382(9896):951-62. doi: 10.1016/S0140-6736(13)60733-3. Epub 2013 Jun 27. Lancet. 2013. PMID: 23810019 Review.

2

Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.

Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles MP, Geddes JR, Hardy R, Lewis G, Mason JM. Barbui C, et al. Cochrane Database Syst Rev. 2000;(4):CD002791. doi: 10.1002/14651858.CD002791. Cochrane Database Syst Rev. 2000. PMID: 11034764 Updated. Review.

3

"Wish bias" in antidepressant drug trials?

Barbui C, Cipriani A, Brambilla P, Hotopf M. Barbui C, et al. J Clin Psychopharmacol. 2004 Apr;24(2):126-30. doi: 10.1097/01.jcp.0000115665.45074.0d. J Clin Psychopharmacol. 2004. PMID: 15206658 Review.

4

Imputing response rates from means and standard deviations in meta-analyses.

Furukawa TA, Cipriani A, Barbui C, Brambilla P, Watanabe N. Furukawa TA, et al. Among authors: barbui c. Int Clin Psychopharmacol. 2005 Jan;20(1):49-52. doi: 10.1097/00004850-200501000-00010. Int Clin Psychopharmacol. 2005. PMID: 15602117

5

Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy.

Andretta M, Ciuna A, Corbari L, Cipriani A, Barbui C. Andretta M, et al. Among authors: barbui c. Soc Psychiatry Psychiatr Epidemiol. 2005 Jan;40(1):72-7. doi: 10.1007/s00127-005-0852-y. Soc Psychiatry Psychiatr Epidemiol. 2005. PMID: 15624078

6

Suicide, depression, and antidepressants.

Cipriani A, Barbui C, Geddes JR. Cipriani A, et al. Among authors: barbui c. BMJ. 2005 Feb 19;330(7488):373-4. doi: 10.1136/bmj.330.7488.373. BMJ. 2005. PMID: 15718515 Free PMC article. No abstract available.

7

Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data.

Brambilla P, Cipriani A, Hotopf M, Barbui C. Brambilla P, et al. Among authors: barbui c. Pharmacopsychiatry. 2005 Mar;38(2):69-77. doi: 10.1055/s-2005-837806. Pharmacopsychiatry. 2005. PMID: 15744630

8

International dosage differences in fluoxetine clinical trials.

Patten S, Cipriani A, Brambilla P, Nosè M, Barbui C. Patten S, et al. Among authors: barbui c. Can J Psychiatry. 2005 Jan;50(1):31-8. doi: 10.1177/070674370505000107. Can J Psychiatry. 2005. PMID: 15754663 Review.

9

Fluoxetine versus other types of pharmacotherapy for depression.

Cipriani A, Brambilla P, Furukawa T, Geddes J, Gregis M, Hotopf M, Malvini L, Barbui C. Cipriani A, et al. Among authors: barbui c. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004185. doi: 10.1002/14651858.CD004185.pub2. Cochrane Database Syst Rev. 2005. PMID: 16235353 Free PMC article. Updated. Review.

10

Imputing missing standard deviations in meta-analyses can provide accurate results.

Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Furukawa TA, et al. Among authors: barbui c. J Clin Epidemiol. 2006 Jan;59(1):7-10. doi: 10.1016/j.jclinepi.2005.06.006. J Clin Epidemiol. 2006. PMID: 16360555

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

508 results

Search Page